Focus Stocks
Pfizer in a very Tight Range
Published on Wednesday, 29 February 2012 09:24 Written by TradersHuddle Wire
New York, February 29th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) closed the trading session at $21.22 placing the price action in a very tight range, given that calculated support is set at $20.80 and the calculated resistance based on an algorithm of peaks and troughs is set at $21.90
Pfizer Inc. (NYSE:PFE), the global pharmaceutical company that develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription and non-prescription pharmaceuticals, and animal health products such as anti-infective medicines and vaccines. Some of Pfizer blockbuster drugs are Celebrex for arthritis pain, and inflammation and acute pain, Viagra for erectile dysfunction, and Lipitor for elevated cholesterol levels in the blood. The company was founded in 1849 and is headquartered in New York, NY.
Pfizer's stock price action indicates that both sellers and buyers are materializing very close to each other, which is indicative to a momentum building area, as the stock can resolve by breaking out of the tight range that developed.
Traders wanting to establish a position should place close attention to Pfizer's price action, as any movement outside its predefined range of $20.80 and $21.90 could grab the attention of momentum buyers, looking for a big movement in the price of the stock. Traders need to be aware that tight range resolution works both ways, hence, a move below support at $20.80 could spark above average selling. A tiered approach can be a good way to approach starting a position in Pfizer's, by establishing a starter position while the stock is in the tight range, and then adding to the position as it breaks and closes above resistance.
Related Articles
- FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- Pfizer Teams With EatingWell To Launch Free Mobile App
- Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO
- Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients
- Pfizer Is Near its 50 Day Moving Average
- High Above Average Volume on Pfizer
- Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)
- Pfizer High Volume Day?
- Pfizer High Volume Day?
Related Partner Headlines
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- UPDATE: Pfizer Says Didn't Meet Primary Endpoint - Benzinga
- Dow Today: Pfizer (PFE) Higher - TheStreet.com
- UPDATE: Pfizer Announces FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib - Benzinga
- Pfizer Stock To Go Ex-dividend Tomorrow (PFE) - TheStreet.com
- UPDATE: Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults - Benzinga
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- Future of Pfizer: It's the R&D, Stupid! - TheStreet.com
- Dow Today: Travelers Companies (TRV) Leads The Day Higher, Pfizer (PFE) Lags - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Consider These Athletic-Looking Charts - TheStreet.com -
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:0.00 (0.00%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:0.00 (0.00%)In The Wires
-
Depomed To Present At Jefferies 2012 Global Health Care Conference -
Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration -
Martin Marietta Materials, Inc. Declares Regular Cash Dividend -
AT&T's Investment In St. Louis Pays Off In Improved Voice And Data Performance -
Equifax To Present At The Stephens Spring Investment Conference -
CHS/Community Health Systems, Inc. Announces Completion of Exchange Offer for Its 8.00% Senior Notes Due 2019 -
InvenSense® Kicks off First Annual Motion Interface Developers Conference -
Tech Data Corporation to Host Annual Meeting of Shareholders on May 30, 2012









